Plasma exchange vs standard care for severe autoimmune hepatitis
Treatments studied
Part of Digestive system, Immune system & allergy clinical trials.
This trial tests whether a procedure called therapeutic plasma exchange (TPE) — which cleans harmful substances from your blood — is more effective than standard medicines for treating severe autoimmune hepatitis. It may be an option if your condition is very serious and you are not able to get a liver transplant within the next month.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 60 years old.
- You have a diagnosis of autoimmune hepatitis (a liver disease where your immune system attacks your liver).
- Your liver disease is severe, measured by a MELD score above 24 (a score that estimates how urgently you need a liver transplant).
- You are not expected to be able to get a liver transplant in the next 28 days.
- You have not taken steroids (medications like prednisone) in the last 7 days.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This test compares two medicines—azathioprine and mycophenolate mofetil (MMF)—to see which is better at putting autoimmune hepatitis into remission without using steroids first. It is for people who have just been diagnosed and haven't started treatment yet.
This trial tests whether a treatment called therapeutic plasma exchange (a process that filters your blood) can help improve the function of other organs in people with severe liver failure. It aims to see if this treatment leads to better outcomes and to find markers that predict who will benefit.
This trial tests whether plasmapheresis (a blood-cleaning procedure) can help people with severe drug-induced liver injury who also have a chronic liver condition. If you qualify, you would receive this treatment to try to reduce liver damage and improve recovery.
This trial tests whether a higher volume of plasma exchange (cleaning the blood to remove toxins) works better than the standard amount for children with acute liver failure who are not improving with usual care.
This trial compares two different amounts of plasma exchange (a treatment that filters your blood) to see which works better for people with sudden liver failure that has caused brain swelling. The goal is to reduce brain swelling and improve survival.
This trial tests whether plasma exchange (a procedure that cleans the blood) can help children with a severe form of autoimmune encephalitis—a condition where the immune system attacks the brain. It's for children who haven't gotten better with standard treatments like steroids or IVIG.
Hear when a new Autoimmune Hepatitis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.